跳至主要内容
临床试验/NCT04299815
NCT04299815已完成不适用

Lactate in the Gut

University of Aarhus1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2020年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
GDF-15

研究概览

简要总结

Lactate is formed naturally in the body in example during physical activity. However, lactate is also formed during food fermentation where certain bacterial strains form lactate. Lactate can also be produced chemically. An example of this is Ringer-lactate which is used for volume replacement when treating dehydrated patients.

As a source of carbon-molecules, lactate is believed to be an important oxidative fuel source in all major organs and yields adenosine triphosphate (ATP) production through Krebs cycle, the Electron Transport Chain in the mitochondria as well as by being a key precursor for gluconeogenesis.

Metformin is the first drug of choice for type 2 diabetes treatment. Use of metformin often results in a small but significant weight loss in overweight users. It is known that metformin increases the lactate concentration in the gut. It is also known also know that metformin use is associated with an increase in blood concentrations of growth differentiation factor 15 (GDF-15). Receptors for GDF-15 can be found in parts of the brain associated with control of appetite. In rats increases in [GDF-15] results in a decrease in appetite and thus weight loss. GDF-15 is thought to be involved in the normal energy homeostasis.

With this study the investigators want to examine the hormonal, metabolic and mechanical effects of lactate in the gut in healthy volunteers. Our hypothesis is that lactate has beneficial effects which may be though an increase in GDF-15 in the blood.

Volunteers will undergo two study days separated by at least 7 days and a maximum of 1 month.

  • On day one volunteers will drink a sodium-lactate solution (intervention). The investigators will also administrate 1500mg paracetamol to assess gastric emptying and do blood samples over 4 hours. The investigators measure [lactate] every 15 min. Every hour the investigators will ask volunteers questions regarding hunger and thoughts of future food intake (questionnaire). After 4 hours of blood sampling the investigators will serve volunteers an all-you-can-eat meal of sandwich and measure how must they ate.
  • On day two volunteers will drink a sodium chloride solution. Furthermore, the investigators administrate intravenous D/L sodium lactate in order to reach the same plasma [lactate] on day 2 as was done on day 1. The rest of day two is identical to day 1.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male gender
  • Age 18-50 years
  • BMI 20-30 kg/m2
  • In good health with no daily use of prescription medicine based on medical history, clinical examination and blood samples.
  • Spoken and written informed consent

排除标准

  • Chronic illness or daily use of prescription medicine .
  • Abnormal screening blood samples as judged by the PI
  • Does not understand or speak Danish

研究组 & 干预措施

Oral lactate

Active Comparator

Sodium D/L lactate solution, 25g/L in 300mL water

干预措施: Oral Sodium Lactate (Drug)

Iso-lactic intravenous lactate infusion

Placebo Comparator

iv sodium D/L lactate to elevate [lactate] to the same levels as measured on day 1 + oral sodium chloride, 300 mL

干预措施: Intravenous sodium lactate (Drug)

结局指标

主要结局

GDF-15

时间窗: 4 hours

Difference in \[GDF-15\] between intervention and placebo

次要结局

  • Evaluation of hunger(4 hours)
  • Gastric inhibitory peptide (GIP)(4 hours)
  • gastric emptying(4 hours)
  • cholecystokinin(4 hours)
  • Gastrin(4 hours)
  • free fatty acid(4 hours)
  • glucagon-like peptide -1(4 hours)
  • Ghrelin(4 hours)
  • C-peptide(4 hours)
  • glucose(4 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验